Optiscan Imaging Limited · ASX:OIL
Optiscan Imaging — Shareholder Meeting (November 2017)
14 slides from Optiscan Imaging's shareholder meeting presentation, Nov 24, 2017
Slide 1: CEO's Address
For personal use only Archie Fraser CEO’s Address Optiscan Imaging Ltd – Annual General Meeting – November 2017
Slide 2: Disclaimer
Disclaimer For personal use only Any forward looking statements in this presentation have been prepared on the basis of a number of assumptions which may prove incorrect and the current intentions, plans, expectations and beliefs about future events are subject to risks, Optiscan Imaging Ltd – Annua
Slide 3: Optiscan's Technology becomes reality
For personal use only becomes reality Optiscan’s Technology Optiscan Imaging Ltd – Annual General Meeting – November 2017
Slide 4: For personal use only
For personal use only Optiscan Imaging Ltd - Investor Presentation – September 2017
Slide 5: The year in review
The year in review For personal use only Significant progress with cornerstone collaboration with Carl Zeiss Meditec for CONVIVO digital Optiscan Imaging Ltd –Annual General Meeting – November 2017 • biopsy product. • Evaluated and advanced discussions with potential distribution partners in North A
Slide 6: Operational update: Carl Zeiss Meditec collaboration
Operational update Carl Zeiss Meditec (CZM) collaboration For personal use only Solid momentum with cornerstone alliance: Optiscan Imaging Ltd – Annual General Meeting – November 2017 • o Delivery of Production Equivalent Systems (PES) in December 2016 and February 2017. o Additional orders for syst
Slide 7: Operational update: Increasing acceptance of CONVIVO in neurosurgery community
Operational update Increasing acceptance of CONVIVO in neurosurgery community For personal use only “…Neuropathologists would be on board with this product as it would help eliminate the one part of the job that is of least Optiscan Imaging Ltd – Annual General Meeting – November 2017 interest – gen
Slide 8: Operational update: ViewnVivo
Operational update ViewnVivo For personal use only Launch of the product in late 2016 with a stand-alone website: www.viewnvivo.com Optiscan Imaging Ltd – Annual General Meeting – November 2017 • • Marketing activity progressing well in overseas markets: o Meetings with 1st-generation preclinical cu
Slide 9: Competitive advantage
Competitive advantage Optiscan Point Scanning Technology For personal use only • Compared to competitive technologies, Optiscan’s technology offer the following advantages: Optiscan Imaging Ltd – Annual General Meeting – November 2017 Higher resolution. 30-fold more image information content.
Slide 10: Operational update: Capital raisings
Operational update Capital raisings For personal use only During FY2017, Company raised $4.1 million through two Placements and a rights issue Optiscan Imaging Ltd – Annual General Meeting – November 2017 • • In October, an additional $3.5 million was raised through a Placement and a Share Purchase
Slide 11: Financial results
Financial results For personal use only Highlights year on year: Optiscan Imaging Ltd – Annual General Meeting – November 2017 FY17 sales up by >A$1m on FY16 (330% increase) Gross profit up 285% R&D Expenses up 74% Cash -27% (30 June) Operating and Financial Overview FY17 FY16 Change Sales R
Slide 12: Growth strategy
Growth strategy Three key pillars for success: For personal use only Commercialising CONVIVO through the CZM collaboration Optiscan Imaging Ltd – Annual General Meeting – November 2017 1. 2. Progressing sales of ViewnVivo – our second-generation preclinical research product 3. Exploring new market o
Slide 13: Outlook
Outlook For personal use only • Optiscan remains on track on its established commercialisation path. Optiscan Imaging Ltd – Annual General Meeting – November 2017 • Driving the business into the production phase for commercial capitalisation of CZM collaboration. • Progressing global sales and distr
Slide 14: Summary
Summary For personal use only • Optiscan remains on track with its commercialisation path. Optiscan Imaging Ltd – Annual General Meeting – November 2017 • Solid progress on the production phase with CZM collaboration. • ViewnVivo commercialisation progressing well with increasing acceptance of the s
Optiscan Imaging — Shareholder Meeting (November 2017) on 6ix